
HEALEY-ALS Platform Trial Undergoes Amendments for ALS Therapy NUZ-001
As it gears up to test its novel therapeutic NUZ-001, Neurizon Therapeutics announced an update to the HEALEY-ALS Platform trial’s master protocol, with changes that include longer trial duration, modified inclusion criteria, and a more patient-centric …